The complex immunological and inflammatory network of adipose tissue in obesity

Molecular Nutrition and Food Research

Volumn 60, Issue 1, 2016, Pages 43-57

  Apostolopoulos, Vasso ^a   de Courten, Maximilian P J ^a   Stojanovska, Lily ^a   Blatch, Gregory L ^a   Tangalakis, Kathy ^a   de Courten, Barbora ^b,c  

^a VICTORIA UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c SOUTHERN HEALTH   (Australia)

Author keywords

Immune cells; Inflammation; Obesity; Weight gain; Weight loss

Indexed keywords

ADIPOCYTOKINE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; EOSINOPHIL; HUMAN; IMMUNOLOGY; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE; MAST CELL; METABOLISM; MORBIDITY; NATURAL KILLER CELL; NEUTROPHIL; OBESITY; PATHOPHYSIOLOGY; PREVALENCE;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; EOSINOPHILS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; KILLER CELLS, NATURAL; MACROPHAGES; MAST CELLS; MORBIDITY; NEUTROPHILS; OBESITY; PREVALENCE;

EID: 84952983645     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500272     Document Type: Review

References (135)

1. Frellick, M., AMA declares obesity a disease, Medscape Medical News, AMA 2013 Annual Meeting 2013, Available from: http://www.medscape.com/viewarticle/806566.
2. Haslam, D., Obesity: a medical history. Obesity Rev. 2007, 8(Suppl 1), 31-36.
3. Sam, S., Adiposity and metabolic dysfunction in polycystic ovary syndrome. Hormone Mol. Biol. Clin. Invest 2015, 21, 107-116.
4. Obesity in Australia. Release 18 July 2015 Available from: www.modi.monash.edu.au/obesity-facts-figures/obesity-in-australia/.
5. Haslam, D. W., James, W. P., Obesity. Lancet 2005, 366, 1197-1209.
6. Bray, G. A. Medical consequences of obesity. J. Clin. Endocrinol. Met. 2004, 89, 2583-2589.
7. Abdullah, A., Wolfe, R., Stoelwinder, J. U., de Courten, M. et al., The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int. J. Epidemiol. 2011, 40, 985-996.
8. Abdullah, A., Stoelwinder, J., Shortreed, S., Wolfe, R. et al., The duration of obesity and the risk of type 2 diabetes. Public Health Nutr. 2011, 14, 119-126.
9. Hassan, M., Latif, N., Yacoub, M., Adipose tissue: friend of foe? Nat. Rev. Cardiology 2012, 9, 689-702.
10. Gest, S., Tseng, Y. H., Kahn, C. R., Developmental origin of fat: tracking obesity to its source. Cell 2007, 131, 242-256.
11. Lehr, S., Hartwig, S., Sell, H., Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics. Clin. App. 2012, 6, 91-101.
12. Enerback, S., The origins of brown adipose tissue. New England J. Med. 2009, 360, 2021-2023.
13. Izzi-Engbeaya, C., Salem, V., Atkar, R. S., Dhillo, W. S., Insights into brown adipose tissue physiology as revealed by imaging studies, Adipocyte 2014, 4, 1-12.
14. Elattar, S., Satyanarayana, A., Can brown fat win the battle against white fat? J. Cell Physiol. 2015, 230, 2311-2317
15. Seale, P., Lazar, M. A., Brown fat in humans: turning up the heat on obesity, Diabetes 2009, 7, 1482-1484.
16. Wang, W., Kissig, M., Rajakumari, S., Huang, L. et al., Ebf2 is a selective marker of brown and beige adipogenic precursor cells. Proc. Natl. Acad. Sci. USA 2014, 111, 14466-14471.
17. Giordano, A., Smorlesi, A., Frontini, A., Barbatelli, G. et al., White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ, Eur. J. Endocrinol. 2014, 170, R159-R171.
18. Duong, M. N., Cleret, A., Matera, E-L., Chettab, K. et al., Adipose cells promotes resistance of breast cancer cells to transtuzumab-mediated antibody-dependent cellular cytotoxicity, Br. Cancer Res. 2015, 17, 57-65.
19. Apostolopoulos, V., de Courten, M., Stojanovska, L., Obesity: an immunological perspective. J. Immune. Res. 2014, 1, 3-5.
20. Ghigliotti, G., Barisione, C., Garibaldi, S., Fabbi, P. et al., Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions, Inflammation. 2014, 37, 1337-1353.
21. Schipper, H. S., Prakken, B., Kalkhoven, E., Boes, M., Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol. Metabol. 2012, 23, 407-415.
22. Hotamisligil, G. S., Shargill, N. S., Spiegelman, B. M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259, 87-91.
23. Uysal, K. T., Wiesbrock, S. M., Marino, M. W., Hotamisligil, G. S., Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389, 610-614.
24. Hotamisligil, G. A., Amer, P., Caro, J. F., Atkinson, R. L. et al., Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995, 95, 2409-2415.
25. Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J. et al., The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to liporotein lipase. J. Clin. Invest. 1995, 95, 2111-2119.
26. Sam, S., Mazzone, T., Adipose tissue changes in obesity and the impact on metabolic function. Transl. Res. 2014, 164, 284-292.
27. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M. et al., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796-1808.
28. Clidir, G., Akincilar, S. C., Tergaonkar, V., Chronid adipose tissue inflammation: all immune cells on the stage. Trends in Mol. Med. 2013, 19, 487-500.
29. Mosser, D. M., Edwards, J. P., Exploring the full spectrum of macrophage activation. Nature Rev. Immunol. 2008, 8, 958-969.
30. Red Eagle, A., Chawla, A., In obesity and weight loss, all roads lead to the mighty macrophage. J. Clin. Invest. 2010, 120, 3437-3440.
31. Kraakman, M. J., Murphy, A. J., Jandeleit-Dahm, K., Kammoun, H. L., Macrophage polarization in obesity and type-2 diabetes: weighing down our understanding of macrophage function. Front. Immunol. 2014, 5, 470-480.
32. Lumeng, C. N., Bodzin, J. L., Saltiel, A. R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization, J. Clin. Invest. 2007, 117, 175-184.
33. Vozarova, B., Metz, C., Stefan, N., Hanson, R. et al., Plasma concentrations of macrophage migration inhibitory factor are associated with insulin resistance and are elevated in Pima Indians compared to Caucasians. Diabetologia 2002, 45, 1739-1741
34. Lumeng, C. N., Deyoung, S. M., Bodzin, J. L., Saltiel, A. R., Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56, 16-23.
35. Xu, H., Barnes, G. T., Yang, Q., Tan, G. et al., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003 112, 1821-1830.
36. Giordano, A., Murano, I., Mondini, E., Perugini, J. et al., Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J. Lipid Res. 2013, 54, 2423-2436.
37. Kanda, H., Tateya, S., Tamori, Y., Kotani, K. et al., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116, 1494-1505.
38. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I. et al., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid. Res. 2005, 46, 2347-2355.
39. Mayi, T. H., Daoudi, M., Derudas, B., Gross, B. et al., Human adipose tissue macrophages display activation of cancer-related pathways. J. Biol. Chem. 2012, 287, 21904-21913.
40. Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J. F. et al., Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue, J. Clin. Invest. 2010, 120, 3466-3479.
41. Cancello, R., Henegar, C., Viguerie, N., Taleb, S. et al., Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54, 2277-2286.
42. Nijhuis, J., Rensen, S. S., Slaats, Y., van Dielen, F. M. et al., Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity 2009, 17, 2014-2018.
43. Wang, Q., Xie, Z., Zhang, W., Zhou, J. et al., Myeloperoxidase deletion prevents high-fat diet-induced obesity and insulin resistance. Diabetes 2014, 63, 4172-4185.
44. Talukdar, S., Oh da, Y., Bandyopadhyay, G., Li, D. et al., Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat. Med. 2012, 18, 1407-1412.
45. Xu, X., Su, S., Wang, X., Barnes, V. et al., Obesity is associated with more activated neutrophils in African American male youth. Int. J. Obesity. 2015, 39, 26-32.
46. Brotfain, E., Hadad, N., Shapira, Y., Avinoah, E. et al., Neutrophil functions in morbidly obese subjects. Clin. Exp. Immunol. 2015, 181, 156-163.
47. Liu, J., Divoux, A., Sun, J., Zhang, J. et al., Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 2009, 15, 940-945.
48. Poglio, S., De Toni-Costes, F., Arnaud, E., Laharrague, P. et al., Adipose tissue as a dedicated reservoir of functional mast cell progenitors. Stem Cells 2010, 28, 2065-2072.
49. Altintas, M.M., Rossetti, M. A., Nayer, B., Puig, A. et al., Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis. 2011, 10, 198-207
50. Salamon, P., Shoham, N. G., Puxeddu, I., Paitan, Y. et al., Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance. J. Allergy Clin. Immunol. 2008, 121, 448-455 e445.
51. Shi, M. A., Shi, G. P., Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans. Front. Immunol. 2012, 3, 7-15.
52. Jorgensen, E. A., Knigge, U., Warberg, J., Kjaer, A., Histamine and the regulation of body weight. Neuroendocrinology 2007, 86, 210-214.
53. Schwartz, C., Eberle, J. U., Voehringer, D., Basophils in inflammation, Eur. J. Pharmacol. 2015, pii: S0014-2999(15)00411-2. doi:10.1016/j.ejphar.2015.04.049
54. Kim, D. J., Noh, J. H., Lee, B. W., Choi, Y. H. et al., The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population. J. Korean Med. Sci. 2008, 23, 193-198.
55. Suzukawa, M., Nagase, H., Ogahara, I., Han, K. et al., Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils. J. Immunol. 2011, 186, 5254-5260.
56. Farr, O. M., Gavrieli, A., Mantzoros, C. S., Leptin applications in 2015: what have we learned about leptin and obesity? Curr. Opin Endocrinol. Diabetes Obes. 2015, 22, 353-359.
57. Chatsigeorgiou, A., Karalis, K. P., Bornstein, S. R., Chavakis, T., Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 2012, 55, 2583-2592.
58. Zhu, J., Paul, W. E., CD4 T cells: fates, functions, and faults. Blood. 2008, 112, 1557-1569.
59. Winer, S., Chan, Y., Paltser, G., Truong, D. et al., Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 2009, 15, 921-929.
60. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K. et al., CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15, 914-920.
61. Yang, H., Youm, Y. H., Vandanmagsar, B., Ravussin, A. et al., Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J. Immunol. 2010, 185, 1836-1845.
62. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A. et al., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009, 15, 930-939.
63. De Rosa, V., Procaccini, C., Cali, G., Pirozzi, G. et al., A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007, 26, 241-255.
64. Wagner, N. M., Brandhorst, G., Czepluch, F., Lankeit, M. et al., Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk Obesity 2013, 21, 461-468.
65. Ahmed, M., Gaffen, S. L., IL-17 in obesity and adipogenesis. Cytokine Growth Fact. Rev. 2010, 21, 449-453.
66. Kanemaru, K., Matsuyuki, A., Nakamura, Y., Fukami, K., Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin 17 and interleukin 22 production in mice. Exp. Dermatol. 2015, 24, 436-442.
67. Pini, M., Fantuzzi, G., Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice. J. Leuk. Biol. 2010, 87, 51-58.
68. Mottaghi, A., Ebrahimof, S., Angoorani, P., Saboor-Yaraghi, A. A., Vitamin A supplementation reduces IL-17 and RORc gene expression in atherosclerotic patients. Scand. J. Immunol. 2014, 80, 151-157.
69. Zhao, R., Tang, D., Yi, S., Li, W. et al., Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes. PloS One 2014, 9, e85770.
70. Zhao, R. X., Li, W. J., Lu, Y. R., Qin, J. et al., Increased peripheral proinflammatory T helper subsets contribute to cardiovascular complications in diabetic patients. Mediators Inflamm. 2014, 2014, 596967.
71. Dalmas, E., Venteclef, N., Caer, C., Poitou, C. et al., T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes 2014, 63, 1966-1977.
72. Fabbrini, E., Cella, M., McCartney, S. A., Fuchs, A. et al., Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterol. 2013, 145, 366-374 e361-363.
73. Treiner, E., Duban, L., Bahram, S., Radosavljevic, M. et al., Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 2003, 422, 164-169.
74. Martin, E., Treiner, E., Duban, L., Guerri, L. et al., Stepwise development of MAIT cells in mouse and human. PLoS Biol. 2009, 7, E54.
75. Kurioka, A., Ussher, J. E., Cosgrove, C., Clough, C. et al., MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol. 2015, 8, 429-440.
76. Serriari, N. E., Eoche, M., Lamotte, L., Lion, J. et al., Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin. Exp. Immunol. 2014, 176, 266-274.
77. Magalhaes, I., Pingris, K., Poitou, C., Bessoles, S. et al., Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J. Clin. Invest. 2015, 125, 1752-1762.
78. Allman, D., Pillai, S., Peripheral B cell subsets. Curr. Opin. Immunol. 2008, 20, 149-157.
79. Agrawal, S., Gollapudi, S., Su, H., Gupta, S., Leptin activates human B cells to secrete TNF-alpha, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J. Clin. Immunol. 2011, 31, 472-478.
80. Nishimura, S., Manabe, I., Takaki, S., Nagasaki, M. et al., Adipose natural regulatory B cells negatively control adipose tissue inflammation. Cell Met. 2013, doi:10.1016/j.cmet.2013.09.017.
81. Duffaut, C., Galitzky, J., Lafontan, M., Bouloumie, A., Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem. Biophys. Res. Comm. 2009, 384, 482-485.
82. Sheng, K. C., Wright, M. D., Apostolopoulos, V., Inflammatory mediators hold the key to dendritic cell suppression and tumor progression. Curr. Med. Chem. 2011, 18, 5507-5518.
83. Chen, Y., Tian, J., Tian, X., Tang, X. et al., Adipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells. PloS One. 2014, 9, e92450.
84. Bertola, A., Ciucci, T., Rousseau, D., Bourlier, V. et al., Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes. 2012, 61, 2238-2247.
85. Kong, Y. Y., Fuchsberger, M., Xiang, S. D., Apostolopoulos, V. et al., Myeloid-derived suppressor cells and their role in diseases. Curr. Med. Chem. 2013, 20, 1437-1444.
86. Poschke, I., Kiessling, R., On the armament and appearances of human myeloid-derived suppressor cells. Clin. Immunol. 2012, 144, 250-268.
87. Gabrilovich, D. I., Ostrand-Rosenberg, S., Bronte, V., Coordinated regulation of myeloid cells by tumours. Nat. Rev. immunol. 2012, 12, 253-268.
88. Hale, M., Itani, F., Buchta, C. M., Wald, G. et al., Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2. PloS One 2015, 10, e0118784.
89. Okwan-Duodu, D., Umpierrez, G. E., Brawley, O. W., Diaz, R., Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am. J. Cancer. Res. 2013, 3, 21-33.
90. Deng, T., Lyon, C. J., Minze, L. J., Lin, J. et al., Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metabol. 2013, 17, 411-422.
91. Ouchi, N., Parker, J. L., Lugus, J. J., Walsh, K., Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85-97.
92. Friedman, J. M., Leibel, R. L., Siegel, D. S., Walsh, J. et al., Molecular mapping of the mouse ob mutation. Genomics 1991, 11, 1054-1062.
93. Zhang, Y., Proenca, R., Maffei, M., Barone, M. et al., Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372, 425-432
94. Loffreda, S., Yang, S. Q., Lin, H. Z., Karp, C. L. et al., Leptin regulates proinflammatory immune responses. FASEB J. 1998, 12, 57-65.
95. Caldefie-Chezet, F., Poulin, A., Tridon, A., Sion, B. et al., Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J. Leukocyte Biol. 2001, 69, 414-423.
96. Caldefie-Chezet, F., Poulin, A., Vasson, M. P., Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radical Res. 2003, 37, 809-817
97. Ohashi, K., Yuasa, D., Shibata, R., Murohara, T. et al., Adiponectin as a target in obesity-related inflammatory state. Endocr. Metab. Disord. Drug Targets 2015, 15, 145-150.
98. Zhang, J., Wu, Y., Zhang, Y., Leroith, D. et al., The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophags. Mol. Endocrin. 2008, 22, 1416-1426.
99. Zhao, P., Elks, C. M., Stephens, J. M., The induction of lipocalin-2 expression in vivo and in vitro. J. Biol. Chem. 2014, 289, 5960-5969.
100. Yang, Q., Graham, T. E., Mody, N., Preitner, F. et al., Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436, 356-362.
101. Moraees-Vieira, P. M., Yore, M. M., Dwyer, P. M., Syed, I. et al., RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab. 2014, 19, 512-526.
102. Fisher, F. M., Chui, P. C., Antonellis, P. J., Bina, H. A. et al., Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010, 59, 2781-2789.
103. Hida, K., Wada, J., Eguchi, J., Zhang, H. et al., Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acas. Sci. USA 2005, 102, 10610-10615.
104. Lazar, M. A., Resistin- and obesity-associated metabolic diseases. Horm. Metab. Res. 2007, 39, 710-716.
105. Moschen, A. R., Kaser, A., Enrich, B., Masheimer, B. et al., Visfatin, and adipocytokine with proinflammatory and immunomodulating properties, J. Immunol. 2007, 178, 1748-1758.
106. Malide, D., Yewdell, J. W., Bennink, J. R., Cushman, S. W., The export of major histocompatibility complex class I molecules from the endoplasmic reticulum of rat brown adipose cells is acutely stimulated by insulin. Mol. Biol. Cell. 2001, 12, 101-114.
107. Wang, Z., Yang, L., Jiang, Y., Ling, Z-Q. et al., High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of IL-22. PLoS One 2011, 6, e23737.
108. Huh, J. Y., Kim, J. I., Park, Y. J., Hwang, I. J. et al., A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol. Cell Biol. 2013, 33, 328-339.
109. Ye, J., Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes Front. Med. 2014, 9, 139-145.
110. Sun, J., Yuan, Y., Cai, R., Sun, H. et al., An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials. BMJ Open. 2015, 5, e007280.
111. Yang, H., Chang, J., Chen, W., Zhao, L. et al., Treadmill exercise promotes interleukin 15 expression in skeletal muscle and interleukin 15 receptor alpha expression in adipose tissue of high-fat diet rats. Endocrine. 2013, 43, 579-585.
112. Gordy, L. E., Bezbradica, J. S., Flyak, A. I., Spencer, C. T. et al., IL-15 regulates homeostasis and terminal maturation of NKT cells. J. Immunol. 2011, 187, 6335-6345.
113. Barra, N. G., Chew, M. V., Reid, S., Ashkar, A. A., Interleukin-15 treatment induces weight loss independent of lymphocytes. PloS One. 2012, 7, e39553.
114. Lynch, L., Nowak, M., Varghese, B., Clark, J. et al., Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity. 2012, 37, 574-587.
115. Hams, E., Locksley, R. M., McKenzie, A. N., Fallon, P. G., Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J. Immunol. 2013, 191, 5349-5353.
116. Trapani, J. A., Smyth, M. J., Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2002, 2, 735-747.
117. Revelo, X. S., Tsai, S., Lei, H., Luck, H. et al., Perforin is a novel immune regulator of obesity-related insulin resistance. Diabetes 2015, 64, 90-103.
118. Fulkerson, P. C., Rothenberg, M. E., Targeting eosinophils in allergy, inflammation and beyond. Nat. Rev. Drug, Discov. 2013, 12, 117-129.
119. Wu, D., Molofsky, A. B., Liang, H. E., Ricardo-Gonzalez, R. R. et al., Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332, 243-247.
120. Qiu, Y., Nguyen, K. D., Odegaard, J. I., Cui, X. et al., Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014, 157, 1292-1308.
121. Vozarova, B., Weyer, C., Lindsday, R. S., Pratley, R. E. et al., high white blood cell count is associated with a worsening of insuling sensitivity and predicts the development of type 2 diabetes. Diabetes 2002, 51, 455-461.
122. Sourris, K. C., Lyons, J. G., de Courten, M. P. J., Dougherty, S. L. et al., c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals. Diabetes 2009, 58, 1259-1266
123. Ozawa, K., Miyazaki, M., Matsuhisa, M., Takano, K. et al., The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes 2005, 54, 657-663.
124. Nakatani, Y., Kaneto, H., Kawamori, D., Yoshiuchi, K. et al., Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 2005, 280, 847-851.
125. Kurucz, I., Morva, A., Vaag, A., Eriksson, K. F. et al., Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 2002, 51, 1102-1109.
126. Bruce, C. R., Carey, A. L., Hawley, J. A., Febbraio, M. A., Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 2003, 52, 2338-2345.
127. Rodrigues-Krause, J., Krause, M., O'Hagan, C., De Vito, G. et al., Divergence of intracellular and extracellular HSP72 in type 2 diabetes: does fat matter? Cell Stress Chaperones 2012, 17, 293-302.
128. Henstridge, D. C., Forbes, J. M., Penfold, S. A., Formosa, M. F. et al., The relationship between heat shock protein 72 expression in skeletal muscle and insulin sensitivity is dependent on adiposity. Metabol. Clin. Exp. 2010, 59, 1556-1561
129. Chung, J., Nguyen, A. K., Henstridge, D. C., Holmes, A. G. et al., HSP72 protects against obesity-induced insulin resistance. Proc. Natl. Acad. Sci. USA 2008, 105, 1739-1744.
130. Henstridge, D. C., Bruce, C. R., Drew, B. G., Tory, K. et al., Activating HSP72 in rodent skeletal muscle increases mitochondrial number and oxidative capacity and decreases insulin resistance. Diabetes 2014, 63, 1881-1894.
131. Klein, S., Fontana, L., Young, V. L., Coggan, A. R. et al., Absence of an effect of liposuction on insulin action and risk factors for coronary hearth disease. N. Engl. J. Med. 2004, 350, 2549-2557.
132. Vozarova, B., Weyer, C., Hanson, K., Tataranni, P. A. et al., Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obesity Res. 2001, 9, 414-417
133. Zhou, Q., Leeman, S. E., Amar, S., Signaling mechanisms in the restoration of impaired immune function due to diet-induced obesity. Proc. Natl. Acad. Sci. USA 2010, 108, 2867-2872.
134. Stojanovska, L., Apostolopoulos, V., Polman, R., Borkoles, E., To exercise or not to exercise, during menopause and beyond. Maturitas 2014, 77, 318-323
135. Apostolopoulos, V., Borkoles, E., Polman, R., Stojanovska, L., Physical and immunological aspects of exercise in chronic diseases. Immunotherapy 2014, 6, 1145-1157